Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Insys Therapeutics, Inc. (INSY)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11
   10-K10-K10-K10-K10-K10-K10-KS-1/A
Net income  -124.5-226.87.658.136.140.4-24.4-1.6
Depreciation and amortization  7.67.36.25.32.51.81.71.4
Asset impairment charges  3.16.27.4-0.3    
Stock-based compensation  12.016.021.621.915.36.32.81.7
Tax benefit from stock-based compensation      -21.4-2.7  
Deferred taxes   23.2-5.6-4.9-0.7-12.0  
Change in working capital   [+]36.4-13.220.125.018.5-10.40.4-6.0
Other operating activities  9.4126.61.6-2.70.40.95.9-10.9
Cash from operations  -56.0-60.758.9102.350.624.2-13.6-15.4
   
Capital expenditures  -6.1-16.7-10.6-13.8-22.2-5.1-1.0-0.6
Sales of short-term investments  121.2130.9104.062.18.2   
Other cash from investing  -61.7-132.1-115.4-138.5-56.2-0.4  
Cash from investing  53.4-17.8-22.0-90.2-70.3-5.5-1.0-0.6
   
Issuance of common stock, net  1.01.3-13.8-13.82.033.3 0.0
Option exercises  1.14.53.89.59.02.10.2 
Other cash from financing  2.29.05.932.639.4-4.915.116.0
Cash from financing  2.15.8-11.79.332.426.315.015.9
   
Free cash flow  -62.1-77.348.388.428.319.1-14.6-16.0
        Per share (diluted)  ($0.84)($1.06)$0.65$1.17$0.39$0.33($1.57)($20.38)
   
Cash paid for interest        0.1 
Cash paid for income taxes  -13.42.110.7     

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy